Payer and clinician insight regarding the integration of comprehensive genomic profiling into routine clinical practice to help oncologists make more informed treatment decisions for patients with cancer.
EP. 4: Molecular Profiling Complexities and Coverage DecisionsJanuary 28th 2022
Considerations regarding coverage decisions to support the large amount of information provided by molecular testing assays and the validity of results in terms of clinical decision-making.
EP. 6: Types of Molecular Assays Used in OncologyFebruary 3rd 2022
Oncologists who manage patients with solid tumors compare and contrast current comprehensive molecular assays being used in clinical practice and discuss reimbursement criteria with payer, Eugean Jiwanmall, MPH, MBA.
EP. 14: Reflex Testing and Reimbursements for Oncology TreatmentMarch 4th 2022
Payer perspective regarding decisions for covering the costs of molecular assays in oncology and reimbursing oncologists for treatments provided to patients while navigating long turnaround times associated with reflex testing.
EP. 15: Future Outlook: Comprehensive Genomic Profiling in OncologyMarch 11th 2022
Expectations regarding the future utilization of comprehensive genomic profiling in clinical practice to assess patients with solid tumor cancers.